These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 2155268

  • 1. Identification of a novel and highly potent eosinophil chemotactic lipid in human eosinophils treated with arachidonic acid.
    Morita E, Schröder JM, Christophers E.
    J Immunol; 1990 Mar 01; 144(5):1893-900. PubMed ID: 2155268
    [Abstract] [Full Text] [Related]

  • 2. Identification of guinea pig eosinophil chemotactic factor of anaphylaxis as leukotriene B4 and 8(S),15(S)-dihydroxy-5,9,11,13(Z,E,Z,E)-eicosatetraenoic acid.
    Sehmi R, Cromwell O, Taylor GW, Kay AB.
    J Immunol; 1991 Oct 01; 147(7):2276-83. PubMed ID: 1655889
    [Abstract] [Full Text] [Related]

  • 3. 5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of human eosinophil migration.
    Powell WS, Chung D, Gravel S.
    J Immunol; 1995 Apr 15; 154(8):4123-32. PubMed ID: 7706749
    [Abstract] [Full Text] [Related]

  • 4. Stereospecificity of leukotriene B4 and structure-function relationships for chemotaxis of human neutrophils.
    Dahinden CA, Clancy RM, Hugli TE.
    J Immunol; 1984 Sep 15; 133(3):1477-82. PubMed ID: 6086758
    [Abstract] [Full Text] [Related]

  • 5. Identification of 5-oxo-15-hydroxy-6,8,11,13-eicosatetraenoic acid as a novel and potent human eosinophil chemotactic eicosanoid.
    Schwenk U, Morita E, Engel R, Schröder JM.
    J Biol Chem; 1992 Jun 25; 267(18):12482-8. PubMed ID: 1618754
    [Abstract] [Full Text] [Related]

  • 6. Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation.
    Tamura N, Agrawal DK, Townley RG.
    J Immunol; 1988 Dec 15; 141(12):4291-7. PubMed ID: 2848892
    [Abstract] [Full Text] [Related]

  • 7. 5-Oxo-eicosanoids are potent eosinophil chemotactic factors. Functional characterization and structural requirements.
    Schwenk U, Schröder JM.
    J Biol Chem; 1995 Jun 23; 270(25):15029-36. PubMed ID: 7797484
    [Abstract] [Full Text] [Related]

  • 8. Identification on receptors for leukotriene B4 expressed on guinea-pig peritoneal eosinophils.
    Sehmi R, Rossi AG, Kay AB, Cromwell O.
    Immunology; 1992 Sep 23; 77(1):129-35. PubMed ID: 1328044
    [Abstract] [Full Text] [Related]

  • 9. Functional properties of guinea pig eosinophil leukotriene B4 receptor.
    Ng CF, Sun FF, Taylor BM, Wolin MS, Wong PY.
    J Immunol; 1991 Nov 01; 147(9):3096-103. PubMed ID: 1655904
    [Abstract] [Full Text] [Related]

  • 10. Effects of novel lipoxygenase products on neutrophil and eosinophil functions in vitro.
    Palmblad J, Udén AM, Friberg I, Ringertz B, Rådmark O, Lindgren JA, Hansson G, Malmsten CL.
    Adv Prostaglandin Thromboxane Leukot Res; 1983 Nov 01; 12():25-31. PubMed ID: 6303087
    [No Abstract] [Full Text] [Related]

  • 11. Mediation of leukocyte components of inflammatory reactions by lipoxygenase products of arachidonic acid.
    Goetzl EJ, Goldman DW, Naccache PH, Sha'afi RI, Pickett WC.
    Adv Prostaglandin Thromboxane Leukot Res; 1982 Nov 01; 9():273-82. PubMed ID: 6283846
    [Abstract] [Full Text] [Related]

  • 12. A novel dioxygenation product of arachidonic acid possesses potent chemotactic activity for human polymorphonuclear leukocytes.
    Shak S, Perez HD, Goldstein IM.
    J Biol Chem; 1983 Dec 25; 258(24):14948-53. PubMed ID: 6317681
    [Abstract] [Full Text] [Related]

  • 13. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
    Wardlaw AJ, Moqbel R, Cromwell O, Kay AB.
    J Clin Invest; 1986 Dec 25; 78(6):1701-6. PubMed ID: 3023451
    [Abstract] [Full Text] [Related]

  • 14. 5-oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of L-selectin shedding, surface expression of CD11b, actin polymerization, and calcium mobilization in human eosinophils.
    Powell WS, Gravel S, Halwani F.
    Am J Respir Cell Mol Biol; 1999 Jan 25; 20(1):163-70. PubMed ID: 9870930
    [Abstract] [Full Text] [Related]

  • 15. Neuropeptides modulate human eosinophil chemotaxis.
    Numao T, Agrawal DK.
    J Immunol; 1992 Nov 15; 149(10):3309-15. PubMed ID: 1385521
    [Abstract] [Full Text] [Related]

  • 16. RANTES is a chemotactic and activating factor for human eosinophils.
    Alam R, Stafford S, Forsythe P, Harrison R, Faubion D, Lett-Brown MA, Grant JA.
    J Immunol; 1993 Apr 15; 150(8 Pt 1):3442-8. PubMed ID: 7682241
    [Abstract] [Full Text] [Related]

  • 17. Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjects.
    Tamura N, Agrawal DK, Suliaman FA, Townley RG.
    Biochem Biophys Res Commun; 1987 Feb 13; 142(3):638-44. PubMed ID: 3030295
    [Abstract] [Full Text] [Related]

  • 18. Montelukast regulates eosinophil protease activity through a leukotriene-independent mechanism.
    Langlois A, Ferland C, Tremblay GM, Laviolette M.
    J Allergy Clin Immunol; 2006 Jul 13; 118(1):113-9. PubMed ID: 16815146
    [Abstract] [Full Text] [Related]

  • 19. The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696.
    Showell HJ, Pettipher ER, Cheng JB, Breslow R, Conklyn MJ, Farrell CA, Hingorani GP, Salter ED, Hackman BC, Wimberly DJ.
    J Pharmacol Exp Ther; 1995 Apr 13; 273(1):176-84. PubMed ID: 7714764
    [Abstract] [Full Text] [Related]

  • 20. Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid.
    Goetzl EJ, Woods JM, Gorman RR.
    J Clin Invest; 1977 Jan 13; 59(1):179-83. PubMed ID: 830662
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.